This thought-provoking book covers the full range of psychopharmacologic practice in textbook fashion, offering a fresh and comprehensive self-examination. Unlike conventional texts of psychopharmacology, this text speaks directly to clinicians who have started to question the limitations of psychopharmacologic claims and the rigid confines of DSM-5 diagnoses. Drawing from their clinical and research experience as well as new literature, the well-published authors provide a new perspective that encourages readers to reevaluate established practices and embrace that medication is just one component of treatment and has limits. The book could be used by psychiatric residents in their course of study, by clinical psychology students taking a psychopharmacology course, or by psychiatrists curious to get a readable but comprehensive look at new critical viewpoints in psychopharmacology that have changed since they were taught. Many neuroscience students who are looking for a review of clinical effects to guide their basic research may also find the proposed text more useful than those texts that collate clinical trials. Current texts are for specialized scientists or are part of multi-authored texts which list drugs alphabetically with no conceptual framework, or books that pretend that each biochemical drug property has a clear and known clinical result presented in cartoon style. Some lesser known texts for psychology or nursing students are not authoritative. Others aimed at patients or families are too simplistic for clinicians. The authors’ goal was to create a unified text expressing their view of psychopharmacology, its evidence base, the unity of its essential principles, and its independence of DSM or ICD diagnosis. Several new history books describe the "rise and fall" of psychopharmacology, the corruption of big pharma and the failure of large controlled clinical trials. Psychopharmacology Reconsidered: A Concise Guide Exploring the Limits of Diagnosis and Treatment ensures that young clinicians are aware of and understand this critical zeitgeist but aware also of the essential core of psychopharmacology and the evidence upon which it rests.

Psychiatry suffers a lot of criticism, not least from within its own scientifically founded medical world. This book provides an account of mental health difficulties and how they are generally addressed in conventional medical circles, alongside critical reviews of the assumptions underpinning them to encourage more humanitarian perspectives.

Psychiatry suffers a lot of criticism, not least from within its own scientifically founded medical world. This book provides an account of mental health difficulties and how they are generally addressed in conventional medical circles, alongside critical reviews of the assumptions underpinning them to encourage more humanitarian perspectives.

Psychopathology: Foundations for a Contemporary Understanding is a comprehensive textbook about the etiology and treatment of the most important psychological disorders. The chapters are written by leading experts in the field of psychopathology who provide up-to-date information on theory, research, and clinical practice. The book is unique in its strong emphasis on critical thinking about psychopathology as represented by chapters on topics such as culture, race, gender, class, clinical judgment, decision-making, and alternatives to traditional categorical approaches to understanding psychopathology. The contributors have incorporated information from the latest DSM-5-TR update, as well as information from the World Health Organization’s International Classification of Diseases. This sixth edition has been updated throughout and includes the most up-date-research on each topic. This book is the go-to textbook on psychopathology for graduate students in clinical and counseling psychology programs and related programs such as social work. It can also be used as a useful reference source for practitioners and researchers.

First published in 1979, Psychedelic Drugs Reconsidered is regarded by many as the most comprehensive, accurate, and accessible analysis of psychedelic drugs for the general reader. It records the extensive history of scientific research on, and societal experience with, psychedelic drugs. The Lindesmith Center reprint edition features a new introduction by the authors on recent developments in psychedelic research, as well as a preface by Dr. Ethan Nadelmann, director of the Lindesmith center.

In the first accessible psychopharmacology text written specifically for psychotherapists. Gitlin explains when to refer patients for consultation about possible medication, how to better treat patients already on medication, and how to work collaboratively with psychopharmacologists. He reviews the criteria for selecting among treatment options and the likely course and side effects of each, and provides case histories to illustrate subtleties in diagnosis. The book also lists all medications by generic and trade names, the side effects and dosage range for each.

Issues for 1974- include the section: Psychopharmacology--a recurring bibliography.

Neuro-psychopharmacology covers the proceedings of the 11th Congress of the Collegium Internationale Neuro-psychopharmacologicum, held in Vienna on July 9-14, 1978. The book focuses on the processes, methodologies, and approaches in neuropsychopharmacology. The selection first offers information on the long-lasting effects of electroconvulsive therapy (ECT) on monoaminergic mechanisms and enhanced monoamine behavioral responses following repeated electroconvulsive shock to rats and their relevance to ECT. The book also underscores the ECT effects on mineral metabolism and neuroendocrine function. The publication reviews the genetic components in the mechanism of action of lithium; genetics and lithium ion metabolism in affective disorders; and pharmacogenetics and the pharmacologic challenge strategy in clinical research. The text also examines the influence of peptides in affective disorders and HLA antigens in affective disorders and cycloid psychoses. Discussions also focus on the biological and clinical basis of the therapeutic effects of benzodiazepines; effects of benzodiazepines on the electrical activity of the central nervous system; and diazepam metabolism in healthy subjects and patients with heart failure, renal failure, and hepatic cirrhosis. The selection is a dependable reference for readers interested in neuropsychopharmacology.

Psychedelic therapies are gaining traction as potential treatments for a wide range of indications, but the structure and delivery of psychedelic therapies are a sharp departure from more traditional models of psychotherapy and pharmacotherapy for psychiatric and other medical disorders. This may be critical to their success. The current volume provides a comprehensive review of the state of the science of psychedelic therapies, including discussion of models and approaches to psychedelic therapies as well as the current status of safety and efficacy data for mood, substance use, trauma, obsessive-compulsive, neurodevelopmental, neurodegenerative disorders, neurological, and inflammatory disorders.